Maastricht University Medical Center+ or Maastricht UMC+ is an academic hospital in the city of Maastricht and affiliated with Maastricht University. Maastricht UMC+ is one of the eight university medical centers in the Netherlands and is part of Netherlands Federation of University Medical Centres

There are 715 beds in Academish Ziekenhuis Maastricht (Azm); Inwendige Geneeskunde.

During the past decade, Academish Ziekenhuis Maastricht (Azm); Inwendige Geneeskunde conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 4 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Academish Ziekenhuis Maastricht (Azm); Inwendige Geneeskunde" #1 collaborator was "Breast International Group" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Academish Ziekenhuis Maastricht (Azm); Inwendige Geneeskunde" are "Anemia" (1 trials), "Breast Cancer" (1 trials), "Gastric Cancer" (1 trials) and "Malignant Melanoma" (1 trials). Many other conditions were trialed in "Academish Ziekenhuis Maastricht (Azm); Inwendige Geneeskunde" in a lesser frequency.

Most popular intervention types in "Academish Ziekenhuis Maastricht (Azm); Inwendige Geneeskunde" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Pertuzumab" (2 trials), "Trastuzumab" (2 trials), "5-Fluorouracil" (1 trials), "Capecitabine" (1 trials) and "Carboplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Academish Ziekenhuis Maastricht (Azm); Inwendige Geneeskunde" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Academish Ziekenhuis Maastricht (Azm); Inwendige Geneeskunde". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Academish Ziekenhuis Maastricht (Azm); Inwendige Geneeskunde, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Academish Ziekenhuis Maastricht (Azm); Inwendige Geneeskunde, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".